Print

Tag: Schlander

Newsletters

Our newsletter features a commentary by Grace-Marie Turner on the major developments and issues of the week as well as summaries of writings by participants in the Health Policy Consensus Group and other articles of interest from the health policy world, plus announcements of coming events. It is emailed in an HTML format from the galen@galen.org email address, via Constant Contact, and you may have to adjust your email settings and junk mailbox to ensure that you don’t miss an issue.
December 5, 2008

Centralization

Most of the health policy proposals offered so far by President-elect Obama and the Democratic leadership in Congress would require much more centralized control over our health sector. Mr. Obama has promised repeatedly, "If you have health insurance, then you don't have to do anything. If you've got health insurance through your employer, you can keep your health insurance, keep your choice of doctor, keep your plan."
Tags:
beagle, Uno, Alan Levine, Bobby Jindal, Louisiana, CoverTN, Phil Bredesen, Tennessee, Medicaid reform, Jeb Bush, Florida, Bob Helms, Medicaid Commission, dual eligibles, capitated model, Lewin Group, Medicaid, accrued debt, Social Security, Medicare, NCPA, Thomas R. Saving, Andrew J. Rettenmaier, Schlander, New York Times, NICE, Britain, health outcomes, universal health care, OECD, Canada, Fraser Institute, Nadeem Esmail, Michael Walker, reform, Council for Excellence in Government, Amy Menefee, Paul Starr, genomics, health care financing, Medicaid, personalized medicine, government run health care, health insurance, Daschle, Obama
Categories:
Health Reform


October 31, 2008

Compare and Decide

Political and policy leaders in the U.S. see a new system of “comparative effectiveness reviews” as a solution to many of our problems in the health sector. This is coming, so we need to pay attention. We invited a leading European authority to conduct a seminar yesterday for our colleagues in the policy community to give us an overview. The idea is that a government-commissioned entity would “compare” various medical and pharmaceutical treatments to determine which are “effective” and make “recommendations” for care.
Tags:
comparative effectiveness, Schlander, NICE, health technology assessments, Institut economique Molinari, Grace-Marie Turner, Obama, insurance, importation, counterfeit drugs, Hawaii, Lichtenberg, prescription drugs, Medicaid, FDA, pre-emption, Calfee, concierge care, Arizona, Proposition 101, Freedom of Choice in Health Care, McCain, Entin, IRET
Categories:
Comparative Effectiveness